Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (5) , 713-718
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2017
- Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystackEuropean Journal of Medicinal Chemistry, 2015
- Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetesBioorganic Chemistry, 2015
- Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenaseEuropean Journal of Medicinal Chemistry, 2014
- Synthesis, antibacterial and antifungal activities of some carbazole derivativesBioorganic & Medicinal Chemistry Letters, 2010
- Synthesis and antitubercular screening of imidazole derivatives☆European Journal of Medicinal Chemistry, 2009
- A Novel Carbazole Derivative, BMVC: a Potential Antitumor Agent and Fluorescence Marker of Cancer CellsChemistry & Biodiversity, 2004
- Synthesis of N-Alkylated derivatives of imidazole as antibacterial agentsBioorganic & Medicinal Chemistry Letters, 2003
- Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agentsProceedings of the National Academy of Sciences, 1999
- Current Advances in the Diagnosis and Treatment of AIDS: An IntroductionClinical Infectious Diseases, 1990